SYF608c77c7bb874995af4e4c7062738ba1Registry ID: 2023-508849-40-00|Active Not RecruitingPhase 4
Loading search results
interventional
N/A
1 country
1
Decrease the incidence of postoperative nausea and vomiting.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 23, 2023
Actual (reported)Incidence of PONV
Severity of PONV measured by NRS (numeric rate scale) and Rhodes scale
Use of rescue medication, type and dose.
Correlation between intraabdominal pressure during surgery and PONV incidence and severity.
Length of stay in recovery room
Length of hospital stay
Subjective patient satisfaction assessment NRS (1-10) of postoperative period.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
Aprepitant Sandoz, 125 mg, kõvakapslid + Aprepitant Sandoz, 80 mg, kõvakapslid
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
CAPSULE, HARD
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
Aprepitant Sandoz, 125 mg, kõvakapslid + Aprepitant Sandoz, 80 mg, kõvakapslid
Named ingredient: Aprepitant
View registry recordAS Bariatric Services
Viimsi, Estonia
Liivi Maddison
First Submitted
December 23, 2023
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Effects of Aprepitant/Dexamethasone Versus Mertazepine /Dexamethasone on Postoperative Nausea and Vomiting
Contact the study team to confirm eligibility.